The structure of dopamine induced alpha-synuclein oligomers.
Rekas
Agata
A
Australian Nuclear Science and Technology Organisation (ANSTO), Menai, NSW, Australia. agata.rekas@ansto.gov.au
Knott
Robert B
RB
Sokolova
Anna
A
Barnham
Kevin J
KJ
Perez
Keyla A
KA
Masters
Colin L
CL
Drew
Simon C
SC
Cappai
Roberto
R
Curtain
Cyril C
CC
Pham
Chi L L
CL
D000682:Amyloid / Q000737:chemistry / Q000378:metabolism; D016227:Benzoquinones / Q000737:chemistry / Q000378:metabolism; D002942:Circular Dichroism; D003432:Cross-Linking Reagents / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology*; D004578:Electron Spin Resonance Spectroscopy; D006863:Hydrogen-Ion Concentration; D008543:Melanins / Q000737:chemistry / Q000378:metabolism; D008715:Methionine / Q000737:chemistry / Q000378:metabolism; D010084:Oxidation-Reduction; D010300:Parkinson Disease / Q000378:metabolism; D017510:Protein Folding / Q000187:drug effects; D055503:Protein Multimerization / Q000187:drug effects* / Q000502:physiology; D017433:Protein Structure, Secondary / Q000187:drug effects; D053838:Scattering, Small Angle; D014461:Ultracentrifugation; D051844:alpha-Synuclein / Q000737:chemistry* / Q000378:metabolism*
D000682:Amyloid; D016227:Benzoquinones; D003432:Cross-Linking Reagents; D008543:Melanins; D051844:alpha-Synuclein; C004532:quinone; D008715:Methionine; D004298:Dopamine